Development and Validation of a Novel Method for Evaluation of Multiple Islet Autoantibodies in Dried Blood Spot Using Dissociation-enhanced Lanthanide Fluorescent Immunoassays Technology, Specific and Suitable for Paediatric Screening Programmes
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Dufrusine B, Natale L, Sallese M, Mozzillo E, Candia F, Cuccurullo I Diabetes Obes Metab. 2024; 27(1):414-418.
PMID: 39429062 PMC: 11618293. DOI: 10.1111/dom.16002.
References
1.
. Newborn screening: toward a uniform screening panel and system--executive summary. Pediatrics. 2006; 117(5 Pt 2):S296-307.
DOI: 10.1542/peds.2005-2633I.
View
2.
Jia X, Yu L
. Understanding Islet Autoantibodies in Prediction of Type 1 Diabetes. J Endocr Soc. 2024; 8(1):bvad160.
PMC: 10758755.
DOI: 10.1210/jendso/bvad160.
View
3.
Ogata A, Tagoh H, Lee T, Kuritani T, Takahara Y, Shimamura T
. A new highly sensitive immunoassay for cytokines by dissociation-enhanced lanthanide fluoroimmunoassay (DELFIA). J Immunol Methods. 1992; 148(1-2):15-22.
DOI: 10.1016/0022-1759(92)90153-k.
View
4.
Cherubini V, Mozzillo E, Iafusco D, Bonfanti R, Ripoli C, Pricci F
. Follow-up and monitoring programme in children identified in early-stage type 1 diabetes during screening in the general population of Italy. Diabetes Obes Metab. 2024; 26(10):4197-4202.
DOI: 10.1111/dom.15779.
View
5.
Dufrusine B, Natale L, Sallese M, Mozzillo E, Candia F, Cuccurullo I
. Development and validation of a novel method for evaluation of multiple islet autoantibodies in dried blood spot using dissociation-enhanced lanthanide fluorescent immunoassays technology, specific and suitable for paediatric screening programmes. Diabetes Obes Metab. 2024; 27(1):414-418.
PMC: 11618293.
DOI: 10.1111/dom.16002.
View